{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:45:29Z","timestamp":1786373129137,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.2215\/cjn.0000000649","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T12:02:58Z","timestamp":1736510578000},"page":"154-155","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring Unintended Consequences from the Prospective Payment System Transitional Drug Add-On Payment Adjustment to Refine Program Enhancement Strategies"],"prefix":"10.2215","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9398-1028","authenticated-orcid":false,"given":"Donald Andrew","family":"Molony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0494-8044","authenticated-orcid":false,"given":"Dia Rose","family":"Waguespack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"issue":"10","key":"B2-20260423","first-page":"465","article-title":"A history of and a vision for CMS quality measurement programs","volume":"38","author":"Goodrich","year":"2012","journal-title":"Jt Comm J Qual Patient Saf."},{"issue":"4","key":"B3-20260423","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/j.ajkd.2011.01.007","article-title":"The 2011 ESRD prospective payment system: welcome to the bundle","volume":"57","author":"Weiner","year":"2011","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B4-20260423","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.2016101079","article-title":"The ESRD quality incentive program\u2013can we bridge the chasm?","volume":"28","author":"Weiner","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B5-20260423","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2215\/CJN.0000000583","article-title":"Incorporation of calcimimetics into end-stage kidney disease bundle: changes in etelcalcitide utilization and parathyroid hormone control following endo of transitional drug add-on payment adjustment designation","volume":"20","author":"Karaboyas","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"215","key":"B6-20260423","first-page":"69023","article-title":"Medicare program; end-stage renal disease prospective payment system, and quality incentive program; final rule. 42 CFR Part 413","volume":"80","year":"2015","journal-title":"Fed Regist."},{"issue":"3","key":"B7-20260423","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.ajkd.2018.11.007","article-title":"Calcimimetics and bundled reimbursement","volume":"73","author":"Lin","year":"2019","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B8-20260423","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial","volume":"317","author":"Block","year":"2017","journal-title":"JAMA."},{"issue":"4","key":"B9-20260423","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ndt\/gfab184","article-title":"Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort","volume":"37","author":"Bozic","year":"2022","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B10-20260423","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:40Z","timestamp":1786369360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000649","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]}}}